How do you manage grade 2-3 chemotherapy- induced peripheral neuropathy (CIPN) developing during adjuvant paclitaxel therapy for breast cancer?  

How would you manage symptoms? How would you adjust the adjuvant regimen (dose reduce, omit paclitaxel etc)? What strategies would you consider for preventing CIPN in other patients undergoing adjuvant paclitaxel?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution